Li, M., Li, N., Fan, Y., Zhang, Z., Zhou, L., Yu, Y., . . . Zhu, T. WDR3 undergoes phase separation to mediate the therapeutic mechanism of Nilotinib against osteosarcoma. BMC.
Chicago Style (17th ed.) CitationLi, Minglei, et al. WDR3 Undergoes Phase Separation to Mediate the Therapeutic Mechanism of Nilotinib Against Osteosarcoma. BMC.
MLA (9th ed.) CitationLi, Minglei, et al. WDR3 Undergoes Phase Separation to Mediate the Therapeutic Mechanism of Nilotinib Against Osteosarcoma. BMC.
Warning: These citations may not always be 100% accurate.